Skip Nav Destination
Issues
15 May 2017
-
Cover Image
Cover Image
IL33 is expressed by vascular endothelial cells and tumor cells in the human colon cancer microenvironment, suggesting their important role in colon cancer. Using multiplexed immunophenotyping microscopy, Fang and colleagues found that PAN-Keratin-positive (green) tumor cells and CD31-positive (blue) vascular endothelial cells expressed IL33 (red) in primary and metastatic colon cancer tissues. When colon cancer cells were IL33-positive, the adjacent colon epithelial cells were IL33 negative. For details, see article by Fang and colleagues on page 2735. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Reviews
Integrated Systems and Technologies
Author Choice
Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
Ruben Casanova; Daniel Xia; Undine Rulle; Paolo Nanni; Jonas Grossmann; Bart Vrugt; Reto Wettstein; Rafael Ballester-Ripoll; Alberto Astolfo; Walter Weder; Holger Moch; Marco Stampanoni; Andrew H. Beck; Alex Soltermann
Microenvironment and Immunology
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2+ Tumors
Mikolaj Medon; Eva Vidacs; Stephin J Vervoort; Jason Li; Misty R. Jenkins; Kelly M. Ramsbottom; Joseph A. Trapani; Mark J. Smyth; Phillip K. Darcy; Peter W. Atadja; Michael A. Henderson; Ricky W. Johnstone; Nicole M. Haynes
Molecular and Cellular Pathobiology
Author Choice
Differential Expression of VEGFA Isoforms Regulates Metastasis and Response to Anti-VEGFA Therapy in Sarcoma
William R. English; Sarah Jane Lunt; Matthew Fisher; Diane V. Lefley; Mohit Dhingra; Yu-Chin Lee; Karina Bingham; Jack E. Hurrell; Scott K. Lyons; Chryso Kanthou; Gillian M. Tozer
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment
Sobeyda B. Gomez-Chou; Agnieszka Katarzyna Swidnicka-Siergiejko; Niharika Badi; Myrriah Chavez-Tomar; Gregory B. Lesinski; Tanios Bekaii-Saab; Matthew R. Farren; Thomas A. Mace; Carl Schmidt; Yan Liu; Defeng Deng; Rosa F. Hwang; Liran Zhou; Todd Moore; Deyali Chatterjee; Huamin Wang; Xiaohong Leng; Ralph B. Arlinghaus; Craig D. Logsdon; Zobeida Cruz-Monserrate
SSRP1 Cooperates with PARP and XRCC1 to Facilitate Single-Strand DNA Break Repair by Chromatin Priming
Ying Gao; Changling Li; Leizhen Wei; Yaqun Teng; Satoshi Nakajima; Xiukai Chen; Jianquan Xu; Brittany Leger; Hongqiang Ma; Stephen T. Spagnol; Yong Wan; Kris Noel Dahl; Yang Liu; Arthur S. Levine; Li Lan
Therapeutics, Targets, and Chemical Biology
Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies
Jonathan Rios-Doria; Jay Harper; Raymond Rothstein; Leslie Wetzel; Jon Chesebrough; Allison Marrero; Cui Chen; Patrick Strout; Kathy Mulgrew; Kelly McGlinchey; Ryan Fleming; Binyam Bezabeh; John Meekin; David Stewart; Maureen Kennedy; Philip Martin; Andrew Buchanan; Nazzareno Dimasi; Emil Michelotti; Robert Hollingsworth
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy
Demin Li; Carol Bentley; Amanda Anderson; Sarah Wiblin; Kirstie L.S. Cleary; Sofia Koustoulidou; Tasneem Hassanali; Jenna Yates; Jenny Greig; Marloes Olde Nordkamp; Iva Trenevska; Nicola Ternette; Benedikt M. Kessler; Bart Cornelissen; Mark S. Cragg; Alison H. Banham
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors
Takayuki Kosaka; Junko Tanizaki; Raymond M. Paranal; Hideki Endoh; Christine Lydon; Marzia Capelletti; Claire E. Repellin; Jihyun Choi; Atsuko Ogino; Antonio Calles; Dalia Ercan; Amanda J. Redig; Magda Bahcall; Geoffrey R. Oxnard; Michael J. Eck; Pasi A. Jänne
Tumor and Stem Cell Biology
IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment
Min Fang; Yongkui Li; Kai Huang; Shanshan Qi; Jian Zhang; Witold Zgodzinski; Marek Majewski; Grzegorz Wallner; Stanislaw Gozdz; Pawel Macek; Artur Kowalik; Marcin Pasiarski; Ewelina Grywalska; Linda Vatan; Nisha Nagarsheth; Wei Li; Lili Zhao; Ilona Kryczek; Guobin Wang; Zheng Wang; Weiping Zou; Lin Wang
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.